- Advertisement -

AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use...

Center for Biotechnology to Showcase Next-Gen Industry Leaders – Business Wire

NEW YORK--(BUSINESS WIRE)--The Center for Biotechnology (CfB) will welcome hundreds of companies, investors and strategic partners from across the country to the Life Sciences...

Sex- And Food-Deprived Fruit Flies Feast before Flirting

Animals make behavioral choices every day. But how do they prioritize one need over another—especially when those choices are both necessary for survival and...

New model rapidly scans the genome of cancer cells and identifies...

Cancer cells can have thousands of mutations in their DNA. However, only a handful of those actually drive the progression of cancer; the rest...

Nahum Arav part of team to discover quasar tsunamis

Credit: Virginia Tech Using the unique capabilities of NASA’s Hubble Space Telescope, a team of astronomers led...

How Bioprocessing Breakthroughs Are Shaping the Future of Medicine

Register Now Panelists: Elena Erroba, PhD Group Chief Commercial Officer3PBIOVIAN View Bio ...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...

Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...

Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with...

more new items

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...

Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with...